文献速递糖尿病肥胖与代谢综合征

2型糖尿病位点的高通量遗传聚类揭示代谢疾病的异质性机制通路

High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.
PubMed 文献 · Diabetologia · 2022-12-20

研究开发高通量流程,基于323个变异×64个特征关联矩阵,用贝叶斯非负矩阵分解对2型糖尿病位点聚类,鉴定出10个遗传聚类,其中4个与胰岛素缺乏相关、5个与胰岛素抵抗相关、1个机制不明,聚类特异性多基因评分与临床特征和结局差异相关。

要点

  • 基于GWAS汇总统计构建323个变异×64个特征关联矩阵,用贝叶斯非负矩阵分解鉴定出10个2型糖尿病遗传聚类。
  • 4个聚类与胰岛素缺乏机制相关,5个与胰岛素抵抗相关,1个机制不明,并显示组织特异性表观基因组富集。
  • 聚类特异性多基因评分在独立队列(N=25,419)中与患者临床特征和结局差异相关。

核心结论

  • 该流程将2型糖尿病位点分层为与不同组织和临床结局相关的生理可解释遗传聚类。

研究设计与样本

  • 研究提取2型糖尿病及相关特征的全基因组关联研究汇总统计,构建323个变异×64个特征关联矩阵,应用贝叶斯非负矩阵分解鉴定遗传成分。
  • 在28种细胞类型和单个胰腺细胞中进行表观基因组富集分析,并在独立队列(N=25,419)中进行聚类特异性多基因评分的回归分析。

主要发现

  • 鉴定出10个遗传位点聚类,重现了先前分析中的5个聚类,并发现与β细胞功能障碍、显著胰岛素分泌以及碱性磷酸酶、脂蛋白A和性激素结合球蛋白水平相关的新聚类。
  • 4个聚类与胰岛素缺乏机制相关,5个与胰岛素抵抗相关,1个机制不明。
  • 两个β细胞聚类在功能性胰腺β细胞状态和应激胰腺β细胞状态中差异富集。
  • 聚类特异性多基因评分与患者临床特征和结局差异相关。
  • 该流程应用于冠状动脉疾病和慢性肾脏病,鉴定出多个与2型糖尿病重叠的聚类。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Type 2 diabetes is highly polygenic and influenced by multiple biological pathways. Rapid expansion in the number of type 2 diabetes loci can be leveraged to identify such pathways. METHODS: We developed a high-throughput pipeline to enable clustering of type 2 diabetes loci based on variant-trait associations. Our pipeline extracted summary statistics from genome-wide association studies (GWAS) for type 2 diabetes and related traits to generate a matrix of 323 variants × 64 trait associations and applied Bayesian non-negative matrix factorisation (bNMF) to identify genetic components of type 2 diabetes. Epigenomic enrichment analysis was performed in 28 cell types and single pancreatic cells. We generated cluster-specific polygenic scores and performed regression analysis in an independent cohort (N=25,419) to assess for clinical relevance. RESULTS: We identified ten clusters of genetic loci, recapturing the five from our prior analysis as well as novel clusters related to beta cell dysfunction, pronounced insulin secretion, and levels of alkaline phosphatase, lipoprotein A and sex hormone-binding globulin. Four clusters related to mechanisms of insulin deficiency, five to insulin resistance and one had an unclear mechanism. The clusters displayed tissue-specific epigenomic enrichment, notably with the two beta cell clusters differentially enriched in functional and stressed pancreatic beta cell states. Additionally, cluster-specific polygenic scores were differentially associated with patient clinical characteristics and outcomes. The pipeline was applied to coronary artery disease and chronic kidney disease, identifying multiple overlapping clusters with type 2 diabetes. CONCLUSIONS/INTERPRETATION: Our approach stratifies type 2 diabetes loci into physiologically interpretable genetic clusters associated with distinct tissues and clinical outcomes. The pipeline allows for efficient updating as additional GWAS become available and can be readily applied to other conditions, facilitating clinical translation of GWAS findings. Software to perform this clustering pipeline is freely available.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kim H, Westerman KE, Smith K, et al. High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease. Diabetologia. 2022. PMID: 36538063. doi:10.1007/s00125-022-05848-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。